3M CO Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
3M CO (MMM) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $222.00 million as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-03
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $222.00M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $267.00M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $249.00M; Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed $275.00M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $259.00M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $222.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $267.00M 10-K · filed 2026-02-03 | |
| 2023-12-31 | $249.00M 10-K · filed 2025-02-05 | $275.00M 10-K · filed 2024-02-07 |
| 2022-12-31 | $259.00M 10-K · filed 2024-02-07 | |
| 2021-12-31 | $249.00M 10-K · filed 2023-02-08 | |
| 2020-12-31 | $231.00M 8-K · filed 2022-04-26 | |
| 2019-12-31 | $218.00M 10-K · filed 2021-02-04 | |
| 2018-12-31 | $203.00M 10-K · filed 2020-02-06 | |
| 2017-12-31 | $210.00M 10-K · filed 2019-02-07 | |
| 2016-12-31 | $302.00M 8-K · filed 2018-05-08 | |
| 2015-12-31 | $305.00M 8-K · filed 2017-05-04 | |
| 2014-12-31 | $290.00M 8-K · filed 2016-05-17 | |
| 2013-12-31 | $322.00M 10-K · filed 2015-02-12 | |
| 2012-12-31 | $415.00M 8-K · filed 2014-05-15 | |
| 2011-12-31 | $483.00M 8-K · filed 2013-05-16 | |
| 2010-12-31 | $501.00M 10-K · filed 2012-02-16 | |
| 2009-12-31 | $473.00M 8-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |